首页 | 本学科首页   官方微博 | 高级检索  
     

3种转换酶抑制剂治疗原发性高血压的成本-效果分析
引用本文:李刚,王小丽,周宏,孙世明. 3种转换酶抑制剂治疗原发性高血压的成本-效果分析[J]. 中国医院用药评价与分析, 2002, 2(4): 215-216
作者姓名:李刚  王小丽  周宏  孙世明
作者单位:1. 四川省人民医院药剂科,成都市,610072
2. 四川省妇幼保健院,成都市,610071
摘    要:目的 :探讨3种转换酶抑制剂治疗原发性高血压所产生的经济效果。方法 :选择186例原发性高血压患者 ,随机分为3组 ,分别给予依那普利、福辛普利、培哚普利 ,运用药物经济学方法进行分析。结果 :依那普利为治疗原发性高血压成本最小的药物。结论 :运用药物经济学的分析方法可使有限资源得到合理配置

关 键 词:成本-效果分析  依那普利  福辛普利  培哚普利
文章编号:2002-04-0215-02
修稿时间:2002-04-11

Cost- effectiveness Analysis of Three Angiotension- converting Enzyme Inhibitors in Treatment of Essential Hypertension
LI Gang,ZHOU Hong,SUN Shiming. Cost- effectiveness Analysis of Three Angiotension- converting Enzyme Inhibitors in Treatment of Essential Hypertension[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2002, 2(4): 215-216
Authors:LI Gang  ZHOU Hong  SUN Shiming
Abstract:OBJECTIVE:To evaluate the economic effectiveness of three angiotension-converting enzyme inhibitor(ACEI) in treating patients with essential hypertension.METHODS:186 patients with essential hypertension were randomly divided into three groups receiving enalapril,fosinopril and perindopril respectively.The results were evaluated with pharmacoeconomic analysis.RESULTS:In treatment of hypertension,enalapril was minimal in cost.CONCLUSION:Therapeutic effect will be improved and cost decreased when pharmacoeconomic cost-effectiveness analysis is used.
Keywords:cost-effectiveness analysis  enalapril  fosinopril  perindopril
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号